You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
13 June 2018
Immungenetics AG: Last Patient Last Visit (LPLV) reached in first part of the DrainAD Study, a Phase 2 trial for the early diagnosis and causative treatment of Alzheimer’s Disease (AD)
23 November 2017
Immungenetics AG initiates ‘DrainAD’ – a Phase II Clinical Study in Alzheimer’s Disease
2 September 2011
Immungenetics AG: Immungenetics AG sets up a cooperation with Prof. Jens Pahnke, M.D. Ph.D., E.F.N., for the further development of the new ‘Alzheimer’s gene’